Compare CRVL & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRVL | VCYT |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 1995 | 2013 |
| Metric | CRVL | VCYT |
|---|---|---|
| Price | $56.37 | $33.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $44.43 |
| AVG Volume (30 Days) | 187.9K | ★ 733.7K |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | ★ 1.53 | 0.82 |
| Revenue | ★ $895,589,000.00 | N/A |
| Revenue This Year | N/A | $13.76 |
| Revenue Next Year | N/A | $12.34 |
| P/E Ratio | ★ $36.54 | $41.54 |
| Revenue Growth | ★ 12.61 | N/A |
| 52 Week Low | $44.83 | $22.61 |
| 52 Week High | $117.22 | $50.71 |
| Indicator | CRVL | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 59.34 | 48.53 |
| Support Level | $51.10 | $31.22 |
| Resistance Level | $71.89 | $33.95 |
| Average True Range (ATR) | 2.04 | 1.53 |
| MACD | 0.29 | 0.34 |
| Stochastic Oscillator | 87.29 | 56.76 |
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).